PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1676600-0	1991	Identification of a catalase-negative sub-population of peroxisomes induced in mouse liver by clofibrate.	Clofibrate	94-104	catalase	Mus musculus	20-28	
12439864-4	2002	Hepatic catalase activity in mice pretreated with CFB (500 mg/kg, i.p., for 10 days) was significantly inhibited by 3-AT (100 or 500 mg/kg, i.p.).	Clofibrate	50-53	catalase	Mus musculus	8-16	
10814892-5	2000	Relative liver weights, CYP4A and activities of catalase and carnitine palmitoyl transferase increased to the same extent in Tg and non-Tg mice treated with clofibrate.	Clofibrate	157-167	catalase	Mus musculus	48-56	
1676600-2	1991	Treatment of mice with clofibrate, a hypolipidemic agent and peroxisome proliferator, resulted in the formation of small particles which were devoid of catalase and urate oxidase, but which were identified as peroxisomal on the basis of content of the clofibrate-induced peroxisomal beta-oxidation enzymes (fatty acyl-CoA oxidase, hydratase/dehydrogenase bifunctional protein, and thiolase) and the 68 kDa peroxisomal integral membrane protein.	Clofibrate	23-33	catalase	Mus musculus	152-160	
2034473-3	1991	By comparison to control pregnancies that received vehicle only, clofibrate produced a 4- to 5-fold increase in the levels of peroxisomal membrane protein 70, a 1.5- to 2-fold increase of dihydroxyacetone phosphate acyltransferase (DHAP-AT) sp act, and a 1.2- to 1.8-fold increase of catalase sp act in fetal liver of 19 d gestation.	Clofibrate	65-75	catalase	Mus musculus	284-292	
2040306-0	1991	Studies on the intracellular distributions of soluble epoxide hydrolase and of catalase by digitonin-permeabilization of hepatocytes isolated from control and clofibrate-treated mice.	Clofibrate	159-169	catalase	Mus musculus	79-87	
2040306-7	1991	(5) The total catalase activity is increased 3.5-fold by clofibrate treatment and 15-35% of this activity is shifted from the peroxisomes to the cytosol.	Clofibrate	57-67	catalase	Mus musculus	14-22	
7126616-2	1982	Repeated administration of aminotriazole to clofibrate-treated mice effectively abolished the elevated catalase activity, but had no significant effect on the reduced plasma triacylglycerol levels.	Clofibrate	44-54	catalase	Mus musculus	103-111	
3181162-0	1988	Immunocytochemical analysis of soluble epoxide hydrolase and catalase in mouse and rat hepatocytes demonstrates a peroxisomal localization before and after clofibrate treatment.	Clofibrate	156-166	catalase	Mus musculus	61-69	
3181162-9	1988	Clofibrate treatment of mice decreased the labeling density of epoxide hydrolase and catalase in hepatocytes peroxisomes, as expected, and more unlabeled peroxisomes were observed.	Clofibrate	0-10	catalase	Mus musculus	85-93	
2274048-4	1990	Differences in catalase leakage from peroxisomes in fractions from untreated mice and clofibrate-treated mice were also apparent following treatments designed to effect membrane permeabilization, as in freeze-thawing, osmotic rupture, and extraction with Triton X-100 and lysophosphatidylcholine.	Clofibrate	86-96	catalase	Mus musculus	15-23	
2721690-0	1989	In vitro translation of cytosolic and peroxisomal epoxide hydrolase and catalase on liver polyribosomes from untreated and clofibrate-treated C57B1/6 mice.	Clofibrate	123-133	catalase	Mus musculus	72-80	
3200253-3	1988	Following treatment of the animals with clofibrate, the specific activity in both peroxisomal and cytoplasmic compartments was increased, with a higher proportion of cytoplasmic catalase being evident in mice.	Clofibrate	40-50	catalase	Mus musculus	178-186	
7126616-0	1982	The effects of clofibrate and 3-amino-1,2,4-triazole on liver catalase and lipid metabolism in mice.	Clofibrate	15-25	catalase	Mus musculus	62-70	
7126616-1	1982	Clofibrate-treated mice showed a significant decrease in plasma triacylglycerols and a parallel elevation of liver catalase.	Clofibrate	0-10	catalase	Mus musculus	115-123	
7126616-3	1982	In mice, the hypolipidemic effect of clofibrate may be dissociated from its capacity to elevate liver catalase.	Clofibrate	37-47	catalase	Mus musculus	102-110	
4208071-6	1974	The absence of sex difference in microbody proliferative response in nafenopin-treated rats and wild type mice is of particular significance, since ethyl-alpha-p-chlorophenoxyisobutyrate (CPIB)-induced microbody proliferation and increase in catalase activity occurred only in males.	Clofibrate	148-186	catalase	Mus musculus	242-250	
4208071-6	1974	The absence of sex difference in microbody proliferative response in nafenopin-treated rats and wild type mice is of particular significance, since ethyl-alpha-p-chlorophenoxyisobutyrate (CPIB)-induced microbody proliferation and increase in catalase activity occurred only in males.	Clofibrate	188-192	catalase	Mus musculus	242-250